Subcommittees and Standards

Showing results 1-33 of 33 matching ACTIVE standards under the jurisdiction of F04.16     F04 Home

E1202-87(2008) Standard Guide for Development of Micronucleus Assay Standards

E1262-88(2008) Standard Guide for Performance of Chinese Hamster Ovary Cell/Hypoxanthine Guanine Phosphoribosyl Transferase Gene Mutation Assay

E1263-97(2008) Standard Guide for Conduct of Micronucleus Assays in Mammalian Bone Marrow Erythrocytes

E1280-97(2008) Standard Guide for Performing the Mouse Lymphoma Assay for Mammalian Cell Mutagenicity

E1397-91(2008) Standard Practice for In Vitro Rat Hepatocyte DNA Repair Assay

E1398-91(2008) Standard Practice for In Vivo Rat Hepatocyte DNA Repair Assay

F619-03(2008) Standard Practice for Extraction of Medical Plastics

F719-81(2012) Standard Practice for Testing Biomaterials in Rabbits for Primary Skin Irritation

F720-81(2012) Standard Practice for Testing Guinea Pigs for Contact Allergens: Guinea Pig Maximization Test
    See also WK39843 proposed revision

F748-06(2010) Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices

F749-13 Standard Practice for Evaluating Material Extracts by Intracutaneous Injection in the Rabbit
    See also WK39845 proposed revision

F750-87(2012) Standard Practice for Evaluating Material Extracts by Systemic Injection in the Mouse

F756-08 Standard Practice for Assessment of Hemolytic Properties of Materials
    See also WK13187 proposed revision

F763-04(2010) Standard Practice for Short-Term Screening of Implant Materials

F813-07(2012) Standard Practice for Direct Contact Cell Culture Evaluation of Materials for Medical Devices

F895-11 Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity

F981-04(2010) Standard Practice for Assessment of Compatibility of Biomaterials for Surgical Implants with Respect to Effect of Materials on Muscle and Bone

F1027-86(2012) Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices

F1408-97(2008) Standard Practice for Subcutaneous Screening Test for Implant Materials

F1439-03(2008) Standard Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials

F1877-05(2010) Standard Practice for Characterization of Particles

F1903-10 Standard Practice for Testing For Biological Responses to Particles In Vitro

F1904-98(2008) Standard Practice for Testing the Biological Responses to Particles in vivo

F1905-98(2003) Standard Practice for Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity (Withdrawn 2011)

F1906-98(2003) Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration (Withdrawn 2011)

F1983-99(2008) Standard Practice for Assessment of Compatibility of Absorbable/Resorbable Biomaterials for Implant Applications

F1984-99(2008) Standard Practice for Testing for Whole Complement Activation in Serum by Solid Materials

F2065-00(2010) Standard Practice for Testing for Alternative Pathway Complement Activation in Serum by Solid Materials

F2147-01(2010) Standard Practice for Guinea Pig: Split Adjuvant and Closed Patch Testing for Contact Allergens

F2148-07(2012) Standard Practice for Evaluation of Delayed Contact Hypersensitivity Using the Murine Local Lymph Node Assay (LLNA)
    See also WK39844 proposed revision

F2151-01 Standard Practice for Assessment of White Blood Cell Morphology After Contact with Materials (Withdrawn 2007)

F2382-04(2010) Standard Test Method for Assessment of Intravascular Medical Device Materials on Partial Thromboplastin Time (PTT)

F2567-06(2010) Standard Practice for Testing for Classical Pathway Complement Activation in Serum by Solid Materials

F2808-10 Standard Test Method for Performing Behind-the-Knee (BTK) Test for Evaluating Skin Irritation Response to Products and Materials That Come Into Repeated or Extended Contact with Skin

F2888-13 Standard Test Method for Platelet Leukocyte Count—An In-Vitro Measure for Hemocompatibility Assessment of Cardiovascular Materials

F2901-13 Standard Guide for Selecting Tests to Evaluate Potential Neurotoxicity of Medical Devices
    See also WK39839 proposed revision

Showing results 1-1 of 1 matching Proposed New Standards under the jurisdiction of F04.16     F04 Home

WK28908 New Test Method for Platelet Leukocyte Count--An In-Vitro Measure for Hemocompatibility Assessment of Cardiovascular Materials

F1905-98(2003) Standard Practice for Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity (Withdrawn 2011)

F1906-98(2003) Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration (Withdrawn 2011)

F2151-01 Standard Practice for Assessment of White Blood Cell Morphology After Contact with Materials (Withdrawn 2007)

Back to the Main Committee Page